Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Mydecine Innovations Group Inc.

Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound
From Mydecine Innovations Group Inc.
Via GlobeNewswire
Tickers CSE:MYCO MYCOF
Mydecine Provides Q4 2023 Business Update
From Mydecine Innovations Group Inc.
Via GlobeNewswire
Tickers CSE:MYCO MYCOF
Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK and First Day of Dealings
From Mydecine Innovations Group Inc.
Via GlobeNewswire
Tickers MYCOF
Mydecine Announces Conditional Approval of CSE Listing
From Mydecine Innovations Group Inc.
Via GlobeNewswire
Tickers MYCOF
Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreement and Provides Update on Its Board of Directors
From Mydecine Innovations Group Inc.
Via GlobeNewswire
Tickers MYCOF
Mydecine Reports its 2023 Annual General Shareholders' Meeting Results
From Mydecine Innovations Group Inc.
Via GlobeNewswire
Tickers MYCOF
Mydecine Reports Positive Preclinical Results on the MYCO-006 Series of its Short-Acting MDMA Analogues
From Mydecine Innovations Group Inc.
Via GlobeNewswire
Tickers MYCOF
Mydecine Innovations Group Provides Corporate Update
From Mydecine Innovations Group Inc.
Via GlobeNewswire
Tickers MYCOF
Mydecine Reports Financial Results for the Year Ended December 2022
From Mydecine Innovations Group Inc.
Via GlobeNewswire
Tickers MYCOF
Mydecine Innovations Group Closes Sale of Its Wholly-Owned Subsidiary, Mindleap Health Inc.
From Mydecine Innovations Group Inc.
Via GlobeNewswire
Tickers CSE:NARA MYCOF
Mydecine Reports Financial Results for the Third Quarter of Fiscal Year 2022
From Mydecine Innovations Group Inc.
Via GlobeNewswire
Tickers MYCOF
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.